MI-EATON
13.9.2022 12:31:36 CEST | Business Wire | Press release
Power management company Eaton announced Royal Power Solutions (RPS), a leading provider of high-precision electrical connectivity components that it acquired earlier this year, is now providing its industry-leading components to commercial vehicle manufacturers. RPS components will be displayed Sept. 20-25 in Eaton’s exhibit at the IAA Transportation show in Hannover, Germany.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220913005003/en/
Eaton’s Royal Power Solutions is an industry-leading provider of critical high-precision power- and signal-distribution terminals and connectors. (Photo: Business Wire)
RPS, established in 1938, is a global leader in the development and production of critical high-precision power- and signal-distribution terminals and connectors. Eaton is utilizing RPS products in its eMobility business and expanding its global market opportunities, including in Europe, Middle East and Africa (EMEA).
“Eaton’s global footprint and diversification have broadened Royal Power Solutions’ reach and ability to grow in EMEA,” said Tom Ross, president, Eaton’s Royal Power Solutions. “The market for terminals and connectors in EMEA continues to expand in parallel with electrification solutions, which are being increasingly adopted by our commercial vehicle customers.”
Electrified commercial vehicles need more power than traditional passenger vehicles to operate varying systems. RPS, recognized for its numerous industry-leading electrical solutions, provides terminals, connectors and other electrical components designed to handle current levels up to 500 amps. Among those components are stamped battery and eyelet terminals that can withstand vibration and harsh environments, making them ideal for commercial vehicles.
High Power Lock Box connectors provide protection, superior performance
Eaton’s RPS specialized High Power Lock Box (HPLB) power connectors are ideal for current electrified commercial vehicle solutions and can help reduce common warranty issues. The HPLB connectors offer superior performance, cost savings and reduced manufacturing complexity. They also provide efficiency and reliability and are strong enough to withstand high-pressure water spray.
HPLB terminals are a “plug-in” solution with a smaller footprint, resulting in less weight and a reduced profile compared to traditional terminals. Eaton’s RPS uses a progressive stamping process to manufacture the HPLB profiles rather than the more costly complex billet machining, stamping and forming process that competitive products require.
Unlike traditional male-to-female terminal connections, Eaton’s RPS HPLB terminals use a unique inverted contact system that provides improved contact force as the temperature increases, creating a stronger connection.
RPS busbars feature low profile, flexibility to meet design requirements
Another RPS component now available to Eaton’s EMEA commercial vehicle customers is RigiFlexTM busbars, manufactured in copper or aluminum based on customer requirements. With a unique, simple, single-piece flow manufacturing process, Eaton can scale volume to meet any customer specification.
The RigiFlex busbar is rigid in some areas but flexible in sections that require elevation changes within the system design. This flexibility also works well across the battery pack in areas that need tolerance for expansion and contraction due to fluctuating temperatures during charging and discharging cycles.
Eaton’s RPS busbars have a low profile to enable space-efficient design without heat sinks, which leads to weight savings. Eaton also can produce busbars with a level of flatness over length unmatched by competitors, which fulfills size and design requirements. Eaton’s RPS can leverage an automated assembly process to provide superior safety, reduce production time and offer maximum cost savings with little wasted material and nearly zero development time for production products.
Eyelet terminals sealed, protected against galvanic corrosion
Eaton’s eyelet terminals, another RPS solution, are crafted with sophisticated engineering and produced in our state-of-the-art stamping facilities. Sourcing eyelet terminals from RPS provides numerous benefits, including the ability to produce billions of parts annually for the single sourcing of large programs.
Traditionally, eyelet terminals in commercial vehicle electrical components are not sealed, exposing them to road spray and salt that accelerate galvanic corrosion. Eaton’s eyelet terminals from RPS provide fully sealed connectors that are resistant to severe vibration and deliver a component service life exceeding customer requirements.
“RPS has decades of design, manufacturing and stamping experience that is being leveraged in the introduction of new energy-transfer technologies,” Ross said. “Many of the components RPS supplies, including eyelets, busbars, High Power Lock Box terminals and full-service connectors, are essential in today’s commercial vehicles.”
Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. Eaton is guided by its commitment to do business right, operate sustainably, and to help its customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, Eaton is accelerating the planet’s transition to renewable energy, helping to solve the world’s most urgent power management challenges, and doing what’s best for its stakeholders and all of society.
Founded in 1911, Eaton has been listed on the NYSE for nearly a century. We reported revenues of $19.6 billion in 2021 and serve customers in more than 170 countries. For more information, visit www.eaton.com. Follow us on Twitter and LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220913005003/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release
First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release
Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
